¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"methylene blue reduction test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® stress test ÇÑ±Û ½ºÆ®·¹½º °Ë»ç
¼³¸í   
  Çù½ÉÁõÀÌ ÀϾ±â ½¬¿î È¯ÀÚ¿¡°Ô¼­ ±× Á¤µµ¸¦ ÆÇ´ÜÇϱâÀ§ÇØ ½ÃÇàÇÑ´Ù. ¹æ¹ýÀº °°Àº °÷¿¡¼­ È¯ÀÚ¸¦ ´Þ¸®µµ·Ï ÇÑ ´ÙÀ½, ¾ó¸¶ÀÇ ¼Óµµ¿¡¼­ Ç÷¾ÐÀÌ ¶³¾îÁö°í Çù½ÉÁõ Áõ»óÀÌ ³ªÅ¸³ª´Â°¡¸¦ °Ë»çÇÑ´Ù.
  
  ´ë°³ ½ÉÇÒ¼ö·Ï ³·Àº ¼Óµµ¿¡¼­µµ Áõ»óÀÌ »¡¸® ³ªÅ¸³­´Ù.
¿µ¹® visual field test ÇÑ±Û ½Ã¾ß°Ë»ç
¼³¸í   
  ´«À» ÇѰ÷¿¡ °íÁ¤½ÃŲ Ã¤, °üÂûÇÒ ¼ö Àִ ÁÖº¯°ø°£À» ½Ã¾ß¶ó ÇÑ´Ù. ½Ã¾ß¸¦ °Ë»çÇϴ °¡Àå °£´ÜÇÑ ¹æ¹ýÀº ´ë¸é°Ë»ç(confronting test)ÀÌ´Ù. À̰ÍÀº Çǰ˻çÀÚÀÇ ´«À» °Ë»çÀÚÀÇ ´«¿¡ ¸ÂÃ߾¸µµ·Ï ÇÏ¿© ´«À» °íÁ¤½ÃŲä, °Ë»çÀÚ°¡ ¼Õ°¡¶ô³¡À» À§ÂÊ, ¾Æ·¡ÂÊ, ¿ÞÂÊ, ¿À¸¥ÂÊ, ±×¸®°í ºñ½ºµëÈ÷ °æ»çÁø °÷ µîÀ¸·Î ¿Å°Üº¸¾Æ Çǰ˻çÀÚ°¡ °üÂûÇÒ ¼ö ÀÖ´ÂÁö ¿©ºÎ¸¦ Á¤Çϴ °Ë»ç¹ýÀÌ´Ù. À̺¸´Ù Á¤È®ÇÑ °Ë»ç¹ýÀº ÀÚµ¿½Ä ÄÄÇ»Åͽþ߰˻ç¹ýÀÌ ÀÖ´Ù. ´ë°³, ´«ÀÚüÀÇ ÀÌ»óÀÌ À־ ½Ã¾ß°Ë»ç¿¡¼­ ÀÌ»óÀÌ ³ª¿ÀÁö¸¸, À̿ܠ³úÀÇ ÀÌ»óÀ¸·Î ½Ã°¢ÀÇ Çü¼º°æ·Î¿¡ ÀÌ»óÀÌ À־ ¿ª½Ã ÀÌ»ó¼Ò°ßÀ» º¸ÀδÙ.
¿µ¹® Draw a person test ÇÑ±Û Àι°È­ ¼º°Ý°Ë»ç
¼³¸í   
  Àι°È­ ¼º°Ý°Ë»ç´Â Ã³À½¿¡´Â Áö´É°Ë»ç·Î °³¹ßµÇ¾ú°í, ±× ÈÄ¿¡´Â »ç¶÷ÀÇ ¹«ÀǽÄÀÇ ¿ä¼Ò¸¦ °Ë»çÇϴ ¹æ¹ýÀ¸·Î ¹ßÀüÇÏ¿´´Ù. °Ë»çÀç·á´Â Áö¿ì°³°¡ Àִ ¿¬Çʰú ¹éÁö¸¦ ÇǰËÀÚ¿¡°Ô ÁÖ°í, »ç¶÷À» ±×·Áº¸¶ó´Â Áö½Ã¸¦ Çϸç, °Ë»çÀڴ ±×¸®´Â ¼ø¼­¿Í Æò°¡¸¦ ±â·ÏÇϰí, ´Ù ±×¸° ÈÄ¿¡´Â ¸ÕÀú¿Í ´Ù¸¥ À̼ºÀ» ±×¸®µµ·Ï ÇÑ´Ù. ÀÌ °Ë»ç¿¡¼­ÀÇ ½ÅüÀÇ ¸ð¾çÀº °ð ÀھƻóÀ» ¹Ý¿µÇѴٴ ÀÔÀå, ±×¸²¿¡¼­ °­Á¶µÈ ±â°üÀº ÀÇ»ç¼ÒÅë¼ö´Ü, °ü³äÈ­, ¿å±¸Ã¼°è, ¼ºÀû ´É·Â, °¥µî, ÁÂÀý°æÇè, ¼ºÀå·Â µîÀ» ¹Ý¿µÇÑ´Ù°í ÇÑ´Ù. À̰ÍÀº ¾Æµ¿°ú ¼ºÀο¡°Ô °³º°Àû ¶Ç´Â Áý´ÜÀûÀ¸·Î ½Ç½ÃÇÒ ¼ö ÀÖ°í, °£ÆíÇϸ鼭µµ À¯ÀÍÇÑ °ÍÀÌ´Ù. ÀÓ»óÀûÀ¸·Î´Â ³úÀÇ ±âÁúÀû º¯È­¸¦ ¾Ë¾Æ³»±â À§ÇÑ ¸ñÀûÀ¸·Îµµ ¸¹ÀÌ ÀÌ¿ëµÈ´Ù.
¿µ¹® intelligence test ÇÑ±Û Áö´É°Ë»ç
¼³¸í   
  1905³â ÇÁ¶û½ºÀÇ ºñ³×°¡ Á¤½Å¹Ú¾à¾Æ¸¦ ÀϹݾƵ¿À¸·ÎºÎÅÍ ÆÇº°Çϱâ À§ÇÏ¿© ÀÛ¼ºÇÑ °ÍÀÌ Áö´É°Ë»çÀÇ ½ÃÀÛÀÌ´Ù. Áö´É°Ë»ç´Â ±×ÀÇ ¸ñÀûÀ¸·ÎºÎÅÍ ÀϹÝÀû Áö´É°Ë»ç¿Í Áø´Ü¿ë Áö´É°Ë»ç·Î ³ª´²Áö°í, ½Ç½Ã¹æ¹ý¿¡¼­ °³Àοë(°³º°½Ä)°ú Áý´Ü¿ë(´Üü½Ä)À¸·Î ºÐ·ùµÇ°í ¶Ç ¹®Á¦ÀÇ ³»¿ëÀ¸·ÎºÎÅÍ ¾ð¾î¼º°Ë»ç(A½Ä ¶Ç´Â ¥á½Ä)¿Í ºñ¾ð¾î¼º°Ë»ç(B½Ä ¥â½Ä)·Î ³ª´²Áø´Ù. Áö´É°Ë»çÀÇ °á°úÀǠǥ½Ã¹ýÀº Á¤½Å¿¬·É(mental age, MA), Áö´ÉÁö¼ö(intelligence quotient, IQ), Áö´ÉÆíÂ÷Ä¡(intelligence standard score, ISS)µîÀÌ ÀÖ´Ù. Áö´É°Ë»ç¿¡´Â ¿ª»çÀûÀ¸·Î ºñ³×½Ä°ú À°±º½ÄÀÇ µÎ °èÅëÀÌ ÀÖ´Ù. ºñ³×½ÄÀº °Ë»çÀÚ°¡ °³º°ÀûÀ¸·Î ÇÑ °³ ¹®Ç×¾¿ Áú¹®À» Çϸé ÀÌ¿¡ ´ëÇÏ¿© Çǰ˻çÀÚ°¡ ¸»À̳ª ÇൿÀ¸·Î ÀÀ´äÇϴ ¹æ¹ý(°³º°½Ä-¹®´ä½Ä)À̰í, À°±º½ÄÀº ÀϹÝÀûÀΠ¹æ½ÄÀ¸·Î´Â ÀμâµÈ ¹®Á¦¿ëÁö¸¦ »ç¿ëÇÏ¿© Çǰ˻çÀÚ°¡ ¼ÒÁ¤ÀÇ ½Ã°£ ³»¿¡ µÇµµ·Ï ¸¹ÀÌ ¹Ù¸£°Ô(½Ã°£Á¦Çѹý) È¸´äÀ» ±âÀÔÇÑ´Ù(Çʱâ¹ý). Çѱ¹ ÃÖÃÊÀÇ Áö´É°Ë»ç´Â 1954³â ¼­¿ï´ëÇб³ »ç¹ü´ëÇР±³À°½É¸®¿¬±¸½Ç¿¡¼­ Á¦ÀÛÇÑ °£Æí Áö´É°Ë»çÀÌ´Ù. °£Æí Áö´É°Ë»ç ÀÌÈÄ ´Ù¼öÀÇ Áý´Ü Áö´É°Ë»ç°¡ ÃâÇöÇÏ¿´´Âµ¥ ºñ±³Àû ÃÖ±Ù¿¡ Ç¥ÁØÈ­µÈ Áö´É°Ë»ç·Î´Â Çѱ¹Çൿ°úÇבּ¸¼Ò°¡ 1984³â¿¡ Àü±¹ °íµîÇб³ ÇлýÀ» ´ë»óÀ¸·Î Á¦ÀÛÇÑ KIT-S Áö´É°Ë»ç°¡ ÀÖ´Ù.
¿µ¹® patch test ÇÑ±Û Ã¸Æ÷°Ë»ç
¼³¸í   
  ÇǺξ˷¹¸£±â¿¡ ´ëÇÑ °Ë»ç¹æ¹ýÀ¸·Î Ç׿øÀ» ºÙÀΠøÆ÷¸¦ ÇǺο¡ ºÎÂøÇÑ ´ÙÀ½ 2ÀÏ ÈÄ¿¡ »çÇϰí, ´Ù½Ã 2ÀÏ ÈÄ¿¡ °Ë»çÇÑ´Ù. 2¹ø ¸ðµÎ ÇǺÎÀÌ»óÀÌ ³ªÅ¸³ª¸é, ¾Ë·¹¸£±â¹ÝÀÀ¿¡ ÀÇÇÑ ÀÌ»ó¼Ò°ßÀ̸ç, ¸¸¾à Ã³À½ 2ÀÏ¿¡´Â ÀÌ»óÀÌ ÀÖÁö¸¸, ´ÙÀ½ 2ÀÏ ÈÄ °Ë»ç¿¡¼­ ÀÌ»ó¼Ò°ßÀÌ ¾øÀ¸¸é, ±×°ÍÀº ´ÜÁö ÇǺÎÀڱؿ¡ ÀÇÇÑ ÀÌ»ó¼Ò°ßÀÏ »ÓÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • blue rubber bleb nevi
    û»ö°í¹«¹°Áý¸ð¹Ý, û»ö°í¹«°Åǰ¸ð¹Ý
  • blue sclera
    û»ö°ø¸·
  • blue to green
    û³ì»ö
  • Evans blue
    ¿¡¹ø½ººí·ç
  • prussian blue reaction
    °¨Ã»¹ÝÀÀ
  • barium reduction
    ¹Ù·ýÁ¤º¹(¼ú)
  • breast reduction
    À¯¹æÁÙÀÓ(¼ú), À¯¹æÃà¼Ò(¼ú)
  • closed reduction
    ºñ°³¹æÁ¤º¹(¼ú), Æó¼âÁ¤º¹(¼ú)
  • forehead reduction
    À̸¶Ãà¼Ò(¼ú), À̸¶¼ºÇü(¼ú)
  • false reduction
    °¡Á¤º¹, °¡È¯³³, °ÅÁþ¸ÂÃã
  • mandibular angle reduction
    ÅλÀ°¢Ãà¼Ò(¼ú), ÇϾǰ¢Ãà¼Ò(¼ú)
  • nitrate reduction
    Áú»ê¿°È¯¿ø
  • open reduction
    °³¹æÁ¤º¹(¼ú)
  • oxidation-reduction
    »êȭȯ¿ø
  • oxidation-reduction potential
    »êȭȯ¿øÀüÀ§
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nitroblue tetrazolium test
    ´ÏÆ®·Îºí·çÅׯ®¶óÁ¹·ý°Ë»ç
  • test strip
    °Ë»ç¶ì
  • test
    °Ë»ç, ½ÃÇè
  • absorption test
    Èí¼ö½ÃÇè, Èí¼ö°Ë»ç
  • agglutination test
    ÀÀÁý°Ë»ç
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • anticholinesterase test
    Ç×Äݸ°¿¡½ºÅ×¶óÁ¦°Ë»ç
  • antiglobulin test
    Çױ۷κҸ°°Ë»ç
  • antimicrobial susceptibility test
    Ç×±ÕÁ¦°¨¼ö¼º°Ë»ç
  • blood test
    Ç÷¾×°Ë»ç
  • blood coagulation test
    Ç÷¾×ÀÀ°í°Ë»ç
  • blood sugar test
    Ç÷´ç°Ë»ç
  • bronchial provocation test
    ±â°üÁöÀ¯¹ß°Ë»ç
  • contraction stress test
    ¼öÃàÀڱذ˻ç
  • Coombs' test
    (¢¡antiglobulin test) ÄñÁî°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • blue sclera
    û»ö°ø¸·
  • blue tumor
    û»öÁ¾
  • toluidine blue
    Åç·çÀ̵òºí·ç
  • prussian blue reaction
    °¨Ã»¹ÝÀÀ
  • breast reduction
    À¯¹æÁÙÀÓ¼ú, À¯¹æÃà¼Ò¼ú
  • closed reduction
    Æó¼â°ñÀý±³Á¤, Æó¼âµÇ¸ÂÃã¼ú
  • egg reduction rate
    Ãæ¶õ°¨¼ÒÀ²
  • false reduction
    °¡Á¤º¹, °¡È¯³³, °ÅÁþ¸ÂÃã
  • forehead reduction
    À̸¶»è°¨¼ú, À̸¶¼ºÇü¼ú
  • mandibular angle reduction
    ÅλÀ°¢Ãà¼Ò¼ú, ÇϾǰ¢Ãà¼Ò¼ú
  • silver reduction method
    ÀºÈ¯¿ø¹ý
  • nitrate reduction
    Áú»ê¿°È¯¿ø
  • oxidation-reduction
    »êȭȯ¿ø
  • open reduction
    °³¹æ°ñÀý±³Á¤, ¿­¸²µÇ¸ÂÃã¼ú
  • oxidation-reduction potential
    »êȭȯ¿øÀüÀ§
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reduction
    ȯ¿ø(ü½êª), °¨¼Ò.
  • reduction
    Á¤º¹, °¨¼Ò
  • reduction discharge
    ȯ¿ø¼º¹æ.
  • reduction division
    °¨¼öºÐ¿­(Êõâ¦ÝÂæñ).
  • reduction division
    °¨¼öºÐ¿­
  • reduction division
    °¨¼öºÐ¿­
  • reduction in area
    ´Ü¸é¼öÃà·ü(Ó¨Øüâ¥õêëÒ).
  • reduction of cardiac work load
    ½ÉÀÛ¾÷·®ÀÇ °æ°¨(ãýíÂåöåÖ¡­ÌîÊõ).
  • reduction of chromosome
    ¿°»öü°¨¼ö(æøßäô÷Êõâ¦).
  • reduction of fraction
    ¾àºÐ(å³ÝÂ).
  • reduction of fracture
    °ñÀý Á¤º¹(Íéï¹ïÚÜÖ).
  • reduction potential
    ȯ¿øÀüÀ§.
  • reduction rhinoplasty
    Ãà¼Òºñ¼ºÇü¼ú
  • reduction semiconductor
    ȯ¿øÇü¹ÝµµÃ¼(ü½êªû¡ÚâÓôô÷).
  • G-test=£¾gonadotropin stimulation test
    °í³ªµµÆ®·ÎÇÉ ÀÚ±ØÅ×½ºÆ®. µµÆ®·ÎÇÉÁö±Ø°Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diagnex blue test
    µð¾Æ±×³Ø½ºÃ»»ö½ÃÇè
  • toluidine blue test
    Åç·çÀ̵ò ºí·ç °Ë»ç
  • closed reduction
    µµ¼öÁ¤º¹(Óùâ¢ïÚÜÙ), ºñ°üÇ÷Àû(°ñ)Á¤º¹¼ú(ުκúìîÜÍéïÚÜÖâú).
  • dose-reduction factor
    ¼±·®°¨¼Ò°è¼ö
  • false reduction
    °¡ ȯ³³(Ê£ü½Ò¡), °¡ Á¤º¹.
  • nitrate reduction
    Áú»ê¿°È¯¿ø(òòß«ç¤ü½êª).
  • open reduction
    °³¹æ¼º Á¤º¹(ËÒÛ¯àõïÚÜÖ), °üÇ÷Àû Á¤º¹ °ñÀý(κúìîÜïÚÜÖÍéï¹), ~ÀÇ .
  • oxidation reduction potential
    »êÈ­-ȯ¿øÀüÀ§
  • oxidation reduction potential =redox p.
    »êȭȯ¿øÀüÀ§.
  • oxidation reduction system =redox s.
    »ê ȭȯ¿ø°è.
  • oxidation reduction titration =redox t.
    »ê ȭȯ¿øÀûÁ¤(¡­îÙïÒ).
  • proportional reduction
    ºñ·Ê°¨·Â(ÝïçÓÊõæ³).
  • reduction
    Á¤º¹¼ú, °¨¼Ò, Ãà¼Ò
  • reduction
    Á¤º¹, °¨¼Ò
  • reduction
    ȯ¿ø(ü½êª), °¨¼Ò.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nitrate reduction
    Áú»êȯ¿ø(òòß«ü½êª)
  • oxidation-reduction enzyme
    »êȭȯ¿ø È¿¼Ò(ß«ûùü½êªý£áÈ)
  • oxidation-reduction potential
    »êȭȯ¿ø ÀüÀ§(ß«ûùü½êªï³êÈ)
  • oxidation-reduction reaction
    »êȭȯ¿ø ¹ÝÀÀ(ß«ûùü½êªÚãëë)
  • plaque reduction method
    ÇöóÅ© °¨¼Ò¹ý(Êõá´Ûö)
  • reduction
    "ȯ¿ø(ü½êª), °¨¼Ò(Êõá´)"
  • reduction division
    °¨¼öºÐ¿­(Êõâ¦ÝÂæñ)
  • reduction phase
    ȯ¿ø±â(ü½êªÑ¢)
  • reduction potential
    ȯ¿ø ÀüÀ§(ü½êªï³êÈ)
  • respiratory reduction
    È£Èí¼º ȯ¿ø(û¼ýåàõü½êª)
  • standard reduction potential
    Ç¥ÁØ È¯¿øÀüÀ§(øöñÞü½êªï³êÈ)
  • sulfate reduction
    Ȳ»êȯ¿ø(üÜß«ü½êª)
  • acrolein test
    ¾ÆÅ©·Ñ·¹ÀνÃÇè (ãËúÐ)
  • acute test
    ´Ü·® µ¶¼º½ÃÇè (Ó¤ÕáÔ¸àõãËúÐ)
  • adrenaline tolerance test
    ¾Æµå·¹³¯¸° ºÎÇϽÃÇè(ݶùÃãËúÐ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • provocative test
    À¯¹ß½ÃÇè
  • pulmonary function test
    Æó±â´É°Ë»ç
  • qualitative test
    Á¤¼º½ÃÇè
  • respiratory function test
    È£Èí±â´É°Ë»ç
  • routine test
    »ó¿ë Å×½ºÆ®
  • screening test
    ¼±º°°Ë»ç, ¿¹ºñ°Ë»ç
  • serologic test
    Ç÷û(ÇÐÀû)°Ë»ç
  • sigle blind test
    ´ÜÀϸͽÃÇè
  • skin test
    ÇǺÎ(¹ÝÀÀ)°Ë»ç
  • supression test
    ¾ïÁ¦°Ë»ç
  • test
    ½ÃÇè, °Ë»ç(¹ý)
  • test object
    ½ÃÇè´ë»ó, Ç¥½Ä¹°
  • test phantom
    Ç¥ÁØÆÒÅÒ
  • test phase
    ½ÃÇè±â
  • thymol turbidity test
    Ƽ¸ôȥʽÃÇè
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EMB embryology; endomyocardial biopsy; engineering in medicine and biology; eosin-methylene blue; ethamb...
MB Bachelor of Medicine [Lat. Medicinae Baccalaureus]; buccal margin; isoenzyme of creatine kinase cont...
MBAS methylene blue active substance
MBD Marchiafava-Bignami disease; Mental Deterioration Battery; methylene blue dye; minimal brain damage;...
MBH2 reduced methylene blue
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
(99m)Tc-MDP 99m)Tc-methylene diphosphonate
MDP 99m)Tc-methylene diphosphonate
alphabeta-meATP Alphabeta-methylene ATP
MC Methylene chloride
MDMS Methylene dimethane sulphonate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • silver reduction method
    Àº ȯ¿ø¹ý
  • TMJ-ID with reduction
    Á¤º¹¼º ¾Ç°üÀý ³»Àå
    ¾Ç°üÀý ³»ÀåÀÇ Ãʱ⠴ܰè·Î ¿Õº¹¼º °üÀýÀ½ÀÌ Æ¯Â¡À¸·Î ³ªÅ¸³­´Ù. ÇÏ¾Ç ¿îµ¿ ¹üÀ§´Â ´ë°³ Á¤»óÀÌ´Ù.
  • blue
    Ǫ¸¥, û»ö
    1. ½ºÆåÆ®·³ÀÇ ÁÖ »ö±òÁß ÇϳªÀÎ Çϴûö. 2. û¸íÇÑ ÇÏ´ÃÀÇ »ö. 3. Ǫ¸¥ »ö±òÀÇ ¹°°¨.
  • blue blindness
    û»ö »ö¸Í
    û»öÀÇ Áö°¢ ½Äº°ÀÌ Àß ¾È µÇ´Â °Í.
  • blue cross
    û½ÊÀÚ
  • blue mark
    û»ö Ç¥½Ã
  • blue nevus
    û»ö ¸ð¹Ý
  • blue sclera
    û»ö °ø¸·
  • blue superficially situated bulging lesion
    õÃþ û»ö À¶±â º´¼Ò
  • blue-black change
    Ã»Èæ º¯È­
  • blue-brown discoloration
    °¥Ã» º¯»ö
  • blue-red center
    Àûû»ö Á᫐ ºÎÀ§
  • blue-yellow blindness
    û-Ȳ »ö¸Í
    û»ö°ú Ȳ»öÀÇ Áö°¢ ½Äº°ÀÌ ºÒ¿ÏÀüÇÑ °Í.
  • Borrel's blue
    º¸·¼Ã»
    ½ºÇÇ·ÎŰŸ ¿°»ö¿¡ ¾²´Â »êÈ­Àº ¿°·á.
  • bromchlorphenol blue
    ºê·Ò Ŭ·Î¸£Æä³î û
    Áö½Ã¾à.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
24-methylene cycloartanol C4-monodemethylase <enzyme> Catalyses the c4 demethylation of 24-methylene cycloartanol to cycloeucalenol; the demethylation involves a 4-methyl-4-hydroxymethyl derivative to a 4-methyl-4-carboxylic acid to a 3-keto-4-methyl cpd to the final cpd; requires NADPH and molecular oxygen; strongly inhibited by cyanide
Registry number: EC 1.13.99.-
Synonym: 24-mcmdase, 4,4-dimethylsterol 4-demethylase
(26 Jun 1999)
4-methylene-L-glutamine amidohydrolase <enzyme> From peanut leaves
Registry number: EC 3.5.1.-
(26 Jun 1999)
acetyl reduction assay <investigation> A technique for measuring the nitrogen fixation activity in photosynthetic organisms. It uses a flame ionisation detector and a gas chromatography apparatus to determine the reduction of acetylene to ethylene by the enzyme nitrogenase.
(06 May 1997)
reduction <orthopaedics, surgery> The correction of a fracture, dislocation or hernia.
(18 Nov 1997)
reduction deformity Congenital absence or attenuation of one or more body parts; usually of the limbs or limb components.
(05 Mar 2000)
reduction division The first cell division in meiosis, the process by which germ cells are formed. A unique event in which the chromosome number is reduced from diploid (46 chromosomes) to haploid (23 chromosomes). Also called first meiotic division or first meiosis.
(12 Dec 1998)
reduction en masse Reduction of hernial sac and contents, so that intestinal obstruction is still present.
(05 Mar 2000)
reduction mammaplasty Plastic surgery of the breast to reduce its size and (frequently) to improve its shape and position.
(05 Mar 2000)
reduction nucleus A nucleus that degenerates in the cell during the changes incident to fertilization.
(05 Mar 2000)
reduction of chromosomes The process during meiosis whereby one member of each homologous pair of chromosomes is distributed to a sperm or ovum; the diploid set of chromosomes (46 in humans) is thus reduced to the haploid set in each gamete; union of the sperm and ovum then restores the diploid or somatic number in the one-cell zygote.
(05 Mar 2000)
reduction phase The stage of nuclear changes in the sexual cells during which reduction of the chromosomes takes place; it embraces the cell generations of the spermatocytes and oocytes.
Synonym: reduction phase.
(05 Mar 2000)
reduction potential The inherent tendency of a compound to act as an electron donor or an electron acceptor. Measured in volts.
(09 Oct 1997)
risk reduction Techniques used to reduce your chances of getting a certain cancer. For example: reducing your dietary fat may help prevent breast cancer.
(09 Oct 1997)
closed reduction The physical manipulation of a joint or bone externally (without making a surgical incision) to affect a joint relocation or more proper anatomic alignment of broken bone fragments. Closed reductions are often performed using intravenous analgesics, local anaesthetic nerve blocks or regional anaesthesia.
(27 Sep 1997)
closed reduction of fractures Reduction by manipulation of bone, without incision in the skin.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Oxford blue
    °¨»ö 
  • Russian blue
    ·¯½Ã¾Æ°í¾çÀÌ(¸öÅëÀÌ ±æÂßÇÏ°í ±Í°¡ Å« ûȸ»ö °í¾çÀÌ)
  • baby blue
    ¿¶Àº Ǫ¸¥»ö
  • blue
    Ǫ¸¥;À½¿ïÇÑ;¿ì¿ïÇÑ-ÆÄ¶û;³²ºû ÇÁ
  • blue
    Ǫ¸¥;Çϴûö(û»ö)ÀÇ;³²»öÀÇ;¿ì¿ïÇÑ;ºñ°üÀûÀÎ;(»çŰ¡)¿©ÀÇÄ¡ ¾ÊÀº;Ǫ¸¥ ¿ÊÀ» ÀÔÀº;(¿µ±¹)º¸¼ö´ç(Tory)ÀÇ;(¹Ù¶÷ µîÀÌ)Âù(cold,chill);(ÃßÀÇ,°øÆ÷ µîÀ¸·Î)â¹éÇÑ;(¸Â°Å³ª ÇÏ¿©)°ËǪ¸¥;Ǫ¸£Á×Á×ÇÑ;¾ö°ÝÇÑ;µüµüÇÑ;À½¶õÇÑ;¿Ü¼³ÇÑ;ÇнÄÀÌ ÀÖ´Â;ÀÎÅÚ¸®ÀÇ(¿©ÀÚ);ºí·ç½º Á¶ÀÇ
  • blue baby
    û»ö¾Æ(¼±Ãµ¼º ½ÉÁúȯ,ÆäÈ®Àå ºÎÀüÀÇ À¯¾Æ)
  • blue blood
    ¸í¹®(ÇǺΰ¡ Èñ°í Á¤¸ÆÀÌ ºñÃÄ º¸ÀÌ´Â µ¥¼­);±ÍÁ·
  • blue book
    ¿µ±¹ÀÇȸº¸°í¼­;Ǫ¸¥ Ç¥Áö ´ä¾ÈÁö ö;½Å»ç·Ï
  • blue devils
    ¿ì¿ïÁõ
  • blue jeans
    û¹ÙÁö
  • blue laws
    ¾ö¹ý(ÁÖÀÏÀÇ ¿À¶ô,±Ù·Î¸¦ ±ÝÁöÇÑ ½Ä¹ÎÁö ½Ã´ëÀÇû±³µµÀûÀÎ ¹ý·ü)
  • blue monday
    »ç¼øÀýÀüÀÇ¿ù¿äÀÏ;¿ì¿ïÇÑ ¿ù¿äÀÏ
  • blue peter
    Ãâ¹ü±â
  • blue racer
    ¹ìÀÇÀÏÁ¾
  • blue ribbon
    Ä«ÅÍ ÈÆÀåÀÇ)Ǫ¸¥¸®º»;Àϵî»ó;ÃÖ°íÀÇ ¸í¿¹;±ÝÁÖÀÇ È¸¿øÀå
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á